Literature DB >> 2994924

Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.

R C Gehrz, S R Rutzick.   

Abstract

The host response to cytomegalovirus (CMV) involves both humoral and cell-mediated immunity. Because virus-specific cytotoxicity appears to be associated with recovery from CMV infection, we have investigated spontaneous (NK) and cytotoxic T cell (Tc) activity against CMV-infected target cells in normal donors and infants with active CMV infection. Fresh mononuclear cells from seropositive donors expressed low-level, non-MHC-restricted cytotoxic activity that preferentially lysed CMV-infected but not uninfected autologous and allogeneic fibroblasts. No cytotoxic activity was observed when mononuclear cells from seronegative donors were studied. Mononuclear cells from infants with active CMV infection and mononuclear cells from seropositive adults that were pre-incubated with cell-free CMV antigen in bulk culture for 6 days had enhanced cytotoxic activity against CMV-infected target cells sharing one or more class I MHC determinants with the effector cell populations. Selective enrichment or depletion experiments were performed to characterize the effector cell populations involved in the augmented cytotoxic response following in vitro induction with CMV antigen. Purified E-rosette-forming cells expressed increased cytotoxic activity against both virus-infected fibroblasts and the NK target cell, K562. Depletion experiments with monoclonal antibodies and complement indicated that the CMV-specific cytotoxic response involves both an E-rosette-positive, T8+, M1- T-cell subset that most likely represents CMV-specific Tc, and an NK population that can be induced to differentiate by in vitro stimulation with CMV antigen following quantitative NK-cell depletion with monoclonal antibody, B73.1.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994924      PMCID: PMC1577233     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

Authors:  G V Quinnan; J E Manischewitz
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

2.  Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus.

Authors:  Y H Thong; S A Hensen; M M Vincent; D A Fuccillo; W A Stiles; J A Bellanti
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

3.  Lysis of cytomegalovirus-infected human fibroblasts and transformed human cells by peripheral blood lymphoid cells from normal human donors.

Authors:  R D Diamond; R Keller; G Lee; D Finkel
Journal:  Proc Soc Exp Biol Med       Date:  1977-02

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.

Authors:  K K Sethi; I Stroehmann; H Brandis
Journal:  Nature       Date:  1980-08-14       Impact factor: 49.962

6.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

7.  Cytomegalovirus vaccine. Specific humoral and cellular immune responses in human volunteers.

Authors:  R C Gehrz; W R Christianson; K M Linner; K E Groth; H H Balfour
Journal:  Arch Intern Med       Date:  1980-07

8.  Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.

Authors:  M Ho
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

9.  Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes.

Authors:  J M Zarling; P C Kung
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

10.  Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers.

Authors:  R C Gehrz; S C Marker; S O Knorr; J M Kalis; H H Balfour
Journal:  Lancet       Date:  1977-10-22       Impact factor: 79.321

View more
  3 in total

Review 1.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

2.  Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection.

Authors:  G J Boland; G C de Gast; R J Hené; G Jambroes; R Donckerwolcke; T H The; G C Mudde
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 3.  Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging.

Authors:  Joshua J Michel; Patricia Griffin; Abbe N Vallejo
Journal:  Front Immunol       Date:  2016-11-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.